(Total Views: 664)
Posted On: 01/06/2021 10:04:55 PM
Post# of 157708
Cytodyn Execs will fly to S. Korea to increase manufacturing w/ Samsung.
Cytodyn has talked to OWS about help to quickly make/distribute Leronlimab.
Cytodyn huge revenues for HIV, cancer and covid-19, long haulers, NASH.....
Cytodyn's "smashed" with eIND apps for leronlimab, demand is happening.
Reports of "recoveries" w/ Leronlimab coming, from eIND and s/c trial open label.
No reason to suspect Leronlimab's MOA will not be effective for virus mutations
All indications remain strong. Leronlimab has experienced no rejections.
There is absolutely no effective/safe therapeutic for s/c covid-19 patients.
Several countries may be buying Leronlimab prior to any EUA being issued.
The US, many countries, are desperate for a s/c therapeutic.
The need for Leronlimab is massive.
Cytodyn has talked to OWS about help to quickly make/distribute Leronlimab.
Cytodyn huge revenues for HIV, cancer and covid-19, long haulers, NASH.....
Cytodyn's "smashed" with eIND apps for leronlimab, demand is happening.
Reports of "recoveries" w/ Leronlimab coming, from eIND and s/c trial open label.
No reason to suspect Leronlimab's MOA will not be effective for virus mutations
All indications remain strong. Leronlimab has experienced no rejections.
There is absolutely no effective/safe therapeutic for s/c covid-19 patients.
Several countries may be buying Leronlimab prior to any EUA being issued.
The US, many countries, are desperate for a s/c therapeutic.
The need for Leronlimab is massive.
(19)
(1)
